Literature DB >> 18226741

Interim monitoring of efficacy data is important and appropriate.

Matthew R Sydes1, Mahesh K B Parmar.   

Abstract

Mesh：

Year:  2008        PMID： 18226741     DOI： 10.1016/j.jclinepi.2007.08.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  3 in total

1.  Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-01

2.  Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.

Authors:  Matthew R Sydes; Mahesh K B Parmar; Nicholas D James; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Rachel C Morgan; Karen Sanders; Patrick Royston
Journal:  Trials       Date:  2009-06-11       Impact factor: 2.279

Review 3.  A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.

Authors:  Ricardo M Fernandes; Johanna H van der Lee; Martin Offringa
Journal:  BMC Pediatr       Date:  2009-12-13       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.